Market Size & Forecast 2035
The global Internet of Medical Things (IoMT) market is calculated at US$111.44 billion in 2025 and is projected to reach US$1.19 trillion by 2035, growing at a 32.3% CAGR from 2026 to 2035.
IoMT connects medical devices, sensors, software, and healthcare information systems to collect and exchange patient and operational data. The ecosystem includes wearables, stationary medical equipment, implantable devices, device and application management software, and connectivity and support services. Its applications range from telemedicine and patient monitoring to clinical workflow management and smart laboratories.
IoMT’s commercial value depends on whether connected data can be converted into better care coordination, timely clinical response, and efficient use of healthcare resources. This makes interoperability, cybersecurity, device reliability, and integration with clinical records central to market adoption. Remote patient monitoring and home-based care are extending connected medical devices beyond hospital walls, while healthcare providers continue to evaluate the evidence, operating costs, and staffing required to manage incoming data.
Key Market Highlights
- Hardware is identified as the leading component, reflecting demand for connected devices that capture clinical data.
- Wearable, stationary, and implantable devices form the major hardware categories.
- Patient monitoring and remote patient monitoring are important IoMT applications.
- Healthcare providers are a principal end-user group, alongside homecare, clinics, and research institutes.
- North America holds the leading regional position, while Asia-Pacific is identified as the fastest-growing region.
- Data security and privacy remain core adoption requirements as connected devices handle sensitive health information.
Market Drivers and Restraints
Growth in remote and continuous monitoring
Wearables and connected medical devices allow health information to be collected outside routine clinical visits. For chronic conditions, continuous or frequent monitoring can give clinical teams a more complete picture of patient status and support follow-up between appointments. Hospitals and care networks are also extending monitoring into outpatient and home settings.
Demand for connected care workflows
IoMT can link bedside monitors, mobile devices, clinical applications, and information systems. When these connections work reliably, care teams can access patient data across units and care settings, reduce manual transfer of readings, and coordinate care with remote teams. Adoption is strongest where device connectivity addresses a defined clinical or operational need.
Cybersecurity, privacy, and interoperability constraints
Connected devices expand the number of systems that handle health information and create additional security exposure. Inadequate authentication, outdated software, and inconsistent network controls can affect patient privacy and device availability. Interoperability challenges also arise when devices use different data formats or do not connect smoothly to hospital systems. Security controls, patch management, access policies, and lifecycle support therefore influence procurement decisions.
Internet of Medical Things Market Report Scope
| Metrics | Details | |
| CAGR | 32.3% | |
| Market Size Available for Years | 2023-2035 | |
| Estimation Forecast Period | 2026-2035 | |
| Revenue Units | Value (US$ Bn) | |
| Segments Covered | Component | Hardware, Software |
| Application | Telemedicine, Clinical Operations & Workflow Management, Smart Labs, Patient Monitoring, Remote Patient Monitoring, Healthcare Devices, Heart-rate Monitoring, Others | |
| End-User | Healthcare Providers, Homecare Clinics Research Institutes Others | |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa | |
Market Segmentation
By Component
The source identifies hardware and software as the principal component categories. Hardware is the leading component, supported by demand for connected devices that capture and transmit clinical information. Hardware includes wearable devices, stationary devices, implantable devices, and other connected medical equipment. Software includes device management and application management, supporting configuration, monitoring, data handling, and connections to care workflows.
By Application
The market includes telemedicine, clinical operations and workflow management, smart laboratories, patient monitoring, remote patient monitoring, healthcare devices, heart-rate monitoring, and other applications. Patient monitoring and remote monitoring connect physiological data to clinical oversight across locations. Telemedicine combines virtual consultations with device-generated readings, while clinical operations applications focus on connected workflows within healthcare organizations. The source identifies these applications but does not publish individual revenue shares.
By End User
The report segments the market into healthcare providers, homecare, clinics, research institutes, and other end users. Healthcare providers are a central user group because hospitals rely on connected devices for monitoring, diagnostics, and clinical operations. Homecare adoption is supported by remote monitoring and care-at-home models. Clinics and research institutes use connected devices for patient assessment, clinical workflows, and research data collection. The source does not provide numerical shares for these end-user categories.
Regional Analysis
North America holds the leading position in the IoMT market. Demand is supported by connected device adoption, established digital health infrastructure, a broad base of medical technology companies, and use of remote monitoring for chronic conditions. The United States is a major market for connected sensors and wearable medical devices. FDA authorization of sensor-based digital health products also provides a defined regulatory route for certain wearable and home-monitoring applications.
Asia-Pacific is identified as the fastest-growing region. Telehealth investment, expanding healthcare infrastructure, and interest in extending care to rural and underserved populations support adoption. China, India, Japan, and South Korea are relevant markets as providers and technology companies build digital health capabilities. The region’s growth will depend on device affordability, data interoperability, network coverage, and local regulatory requirements.
Europe benefits from connected care initiatives, established medical-device manufacturing, and growing use of digital monitoring across hospital and home settings. Region Stockholm’s hospital-at-home initiative, selected in May 2026, shows how remote monitoring can be incorporated into a large regional care program. The Philips-led consortium’s agreement is designed to support care for up to 15,000 patients annually.
South America is developing IoMT adoption through telemedicine, remote monitoring, and connected healthcare initiatives. Growth depends on healthcare network investment, connectivity outside major cities, and integration with public and private provider systems.
The Middle East and Africa have opportunities in connected monitoring, telemedicine, and healthcare infrastructure modernization. Deployment can help extend access across geographically dispersed populations, though connectivity, device affordability, local technical support, and cybersecurity readiness shape project feasibility.
The report identifies regional rankings and growth direction but does not publish numerical regional shares or country-level market revenue. No unsupported regional percentages are assigned.
Competitive Landscape
Competition spans medical-device manufacturers, connected-care platform providers, software developers, and technology companies. The report names Boston Scientific Corporation, Koninklijke Philips N.V., GE HealthCare, Siemens Healthineers, Medtronic, Honeywell International, Johnson & Johnson, Abbott, ResMed, and BIOTRONIK among the major players.
Companies compete through the breadth of connected-device portfolios, sensor performance, data platforms, interoperability, clinical workflow integration, security, and service support. Healthcare organizations increasingly need systems that connect information across care settings while limiting alarm fatigue and preserving clinical oversight. Remote monitoring partnerships and hospital-at-home programs show how device providers are extending their reach through broader care ecosystems.
Koninklijke Philips N.V.
Philips supplies patient monitoring systems, connected-care platforms, and remote monitoring solutions. Its portfolio spans bedside monitoring and wearable technologies, with an emphasis on connecting patient information across care settings. In May 2026, a Philips-led consortium with Cuviva and Vingmed was selected to support Region Stockholm’s hospital-at-home initiative. The program is designed to monitor complex and chronic patients at home and support hospital-led care across the region.
GE HealthCare
GE HealthCare provides patient monitoring, diagnostic imaging, and healthcare technology systems. In IoMT deployments, its role includes connecting monitoring data and clinical insights to support care teams. The company’s connected monitoring solutions are designed to provide patient data across facilities and care workflows. Integration with hospital information systems and dependable delivery of clinical signals are important factors in its market position.
Medtronic
Medtronic develops connected medical devices and remote monitoring services across areas including cardiac care, diabetes, and patient monitoring. Its remote-monitoring tools allow device information to be transmitted to clinical teams, supporting follow-up beyond in-person visits. The company’s IoMT position is rooted in medical devices that generate longitudinal patient data and software that connects devices with care providers.
Abbott
Abbott participates in IoMT through connected medical technologies, including glucose monitoring and wearable biosensors. Its connected devices transmit readings to compatible digital platforms, helping patients and healthcare professionals monitor health status over time. In August 2026, FDA authorized Abbott Diabetes Care’s Libre Duo 10 Day, a wearable system that continuously monitors ketone levels and blood glucose and sends readings wirelessly to a compatible smartphone.
Strategic Takeaways
- The IoMT market is calculated at US$111.44 billion in 2025 and US$1.19 trillion by 2035, using the source’s 32.3% CAGR.
- Hardware leads the component categories, with connected sensors and monitoring devices anchoring the broader system.
- Patient monitoring and remote patient monitoring are key use cases, linking device data to ongoing clinical oversight.
- North America leads the market, while Asia-Pacific is identified as the fastest-growing region.
- IoMT systems gain practical value when data integrates with clinical workflows and reaches staff who can act on it.
- Cybersecurity, privacy, device lifecycle support, and interoperability are critical selection criteria for healthcare organizations.
- Hospital-at-home programs and wearable technologies are expanding connected monitoring beyond conventional inpatient settings.
Recent Developments
- FDA authorized Abbott’s Libre Duo 10 Day system on August 25, 2026. It is the first wearable device authorized in the United States to continuously monitor ketone levels and the first to track ketones and blood glucose together. Readings are transmitted wirelessly to a compatible smartphone.
- Philips expanded its patient-monitoring ecosystem on August 6, 2026. New collaborations with six technology providers extend integration of wearable and out-of-hospital monitoring data into the Philips ecosystem, supporting continuous monitoring across hospital and home care.
- The FDA selected the first manufacturer for its TEMPO digital health devices pilot on July 22, 2026. The pilot is designed to collect real-world data on digital health devices used to support care for chronic conditions, while maintaining patient-safety oversight.
- Philips and its consortium partners were selected for Region Stockholm’s hospital-at-home initiative on May 18, 2026. The up-to-eight-year agreement is designed to support remote monitoring for up to 15,000 patients annually and provide hospital-led care in home settings.
- The FDA updated its sensor-based digital health device list in September 2026. The listing includes recent authorizations for wearable and sensor-based products, including glucose monitoring and other devices designed for continuous or spot-check monitoring outside clinical settings.
- Medtronic began the EMEA commercial launch of its MiniMed Go Smart MDI system in February 2026. The system combines a glucose sensor with an app to provide real-time insights for people managing diabetes with multiple daily injections.
Why Purchase the Report?
- Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
- Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
- Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
- Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
- Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
- Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
- Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
- Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
- Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
- Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
- Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
- Post-market Surveillance: Uses post-market data to enhance product safety and access.
- Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
The Global Internet of Medical Things (IoMT) market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 276 pages of expert insights, providing a complete view of the market landscape.
Target Audience
- Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
- Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
- Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
- Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
- Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
- Supply Chain: Distribution and Supply Chain Managers.
- Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
- Academic & Research: Academic Institutions.
